Bio-Techne's ROE % for the quarter that ended in Mar. 2024 was 9.87%. Bio-Techne's PB Ratio for the quarter that ended in Mar. 2024 was 5.51.
Bio-Techne's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 1.79%.
Bio-Techne ROE % Adjusted to Book Value Historical Data
The historical data trend for Bio-Techne's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bio-Techne's ROE % Adjusted to Book Value
For the Biotechnology subindustry, Bio-Techne's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Bio-Techne's ROE % Adjusted to Book Value falls into.
Bio-Techne ROE % Adjusted to Book Value Calculation
Bio-Techne's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of Bio-Techne's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your 